Welcome to Beijing Cimin ilaya Biotechnology Co., Ltd.

Established in 2017, Beijing Cimin ilaya Biotechnology Co., Ltd. stands at the forefront of stem cell research and application in China. Our early engagement in this field has fostered extensive academic and technical collaborations with leading experts and institutions in the United States, Japan, Australia, Germany, Ukraine, and other nations renowned for their contributions to cell research.

Our commitment extends to providing cutting-edge solutions for various medical challenges. With a focus on diabetes treatment, spinal cord and brain injury repair, neurological disease and sequelae treatment, heart disease and sequelae treatment, orthopedic disease treatment, autism treatment, refractory diseases due to low immune system function, immune-boosting treatment, and anti-aging therapies, we have successfully served patients and anti-aging enthusiasts from China, the Middle East, Southeast Asia, Russia, Central Asia, Africa, and beyond.

Having garnered expertise in over 34,000 cases of stem cell applications for disease treatment and anti-aging interventions, our track record speaks to the efficacy of our innovative approach.

At the heart of our success is a distinguished team led by a renowned doctor specializing in stem cell culture. Complemented by a group of skilled practitioners applying stem cells in clinical therapy, we ensure the highest standards of care for our patients.

Our state-of-the-art R&D stem cell laboratory, the first of its kind in China, underscores our commitment to advancing the frontiers of stem cell science. Additionally, our partnerships with outstanding hospitals and traditional Chinese medicine (TCM) treatment and rehabilitation management further enhance the comprehensive care we provide.

Discover a new era in healthcare with Beijing Cimin ilaya Biotechnology Co., Ltd., where pioneering research meets compassionate patient care.